EKF Diagnostics Holdings (EKF.L) Stock Analysis & Winston Score
EKF Diagnostics is a UK-based medical device company that makes small machines and test kits used to measure things like blood sugar, hemoglobin, and other markers in a patient's blood. Its products are used by hospitals, clinics, and point-of-care settings — meaning tests happen right where the patient is, not in a big lab. The company also makes fermentation monitoring equipment used by life science and biotech customers. EKF earns money by selling both the testing devices and the consumable reagents and test strips that customers need to keep using those machines — this repeat-purchase model provides a steady revenue stream. It operates across the UK, US, Germany, and other international markets, and its installed base of instruments creates some switching costs since customers tend to stick with compatible consumables. The main growth opportunity lies in expanding point-of-care testing in emerging markets, while the key risk is competition from larger diagnostics companies with greater scale and distribution reach.
Winston Score: 49/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Good (15/30)
- Growth: Weak (3/20)
- Cash Flow: Exceptional (9/10)
- Stability: Good (5/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: 25.40 GBp
Market Cap: £109M
Sector: Healthcare
Industry: Medical - Devices
Exchange: London Stock Exchange



